Strategic Direction
Volume 32, Issue 9, 2016, Pages 19-21

Cross-border M&A originating from developing countries (The case of the Indian pharmaceutical industry) (Note)

Amir-Aslani A.* , Chanel M.A.
  • a Department of Management and Technology, Grenoble Ecole de Management, Grenoble, France
  • b Department of Strategy and Finance, Grenoble Ecole de Management, Grenoble, France

Abstract

Purpose: The paper aims to highlight the growing use of M&A as a strategic tool by companies originating from the emerging markets. Findings: Cross-border mergers play an increasingly important role in the strategies of firms originating from developing countries in expanding their capabilities and expertise within the drug discovery value chain by providing world class service and international business knowledge. Originality/value: M&A literature is very extensive. However, there is need for more research focusing on M&A activity originating from emerging countries. © 2016, © Emerald Group Publishing Limited.

Author Keywords

Drug discovery Cross-border M%26A Pharmaceutical Developing countries

Index Keywords

[No Keywords available]
Link
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84988642959&doi=10.1108%2fSD-05-2016-0062&partnerID=40&md5=ed39b37697e5406c4f6de9c4922dc420
DOI: 10.1108/SD-05-2016-0062
ISSN: 02580543
Original Language: English